Listed

Tyra Biosciences, Inc.

TYRANasdaqCIK 1863127HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$49.0m, Q2 FY2026
Net income−$45.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m19.3Research and development, Q3 FY2023, three months to 2023-09-30$19.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figure20.7Research and development, Q4 FY2023, three months to 2023-12-31$20.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0000950170-25-046124. Derived: 12-month figure less the 9-month figure.Report this figure17.2Research and development, Q1 FY2024, three months to 2024-03-31$17.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure18.0Research and development, Q2 FY2024, three months to 2024-06-30$18.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0000950170-25-108899.Report this figure22.7Research and development, Q3 FY2024, three months to 2024-09-30$22.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure22.2Research and development, Q4 FY2024, three months to 2024-12-31$22.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001193125-26-085490. Derived: 12-month figure less the 9-month figure.Report this figure25.0Research and development, Q1 FY2025, three months to 2025-03-31$25.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure24.3Research and development, Q2 FY2025, three months to 2025-06-30$24.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure25.5Research and development, Q3 FY2025, three months to 2025-09-30$25.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure28.2Research and development, Q4 FY2025, three months to 2025-12-31$28.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001193125-26-085490. Derived: 12-month figure less the 9-month figure.Report this figure33.5Research and development, Q1 FY2026, three months to 2026-03-31$33.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure39.2Research and development, Q2 FY2026, three months to 2026-06-30$39.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure
Selling, general and administrative$m0.0Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2023-11-07, accession 0000950170-23-060276.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(24.0)Operating income, Q3 FY2023, three months to 2023-09-30−$24.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figure(25.6)Operating income, Q4 FY2023, three months to 2023-12-31−$25.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0000950170-25-046124. Derived: 12-month figure less the 9-month figure.Report this figure(22.3)Operating income, Q1 FY2024, three months to 2024-03-31−$22.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure(23.5)Operating income, Q2 FY2024, three months to 2024-06-30−$23.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0000950170-25-108899.Report this figure(28.6)Operating income, Q3 FY2024, three months to 2024-09-30−$28.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure(29.7)Operating income, Q4 FY2024, three months to 2024-12-31−$29.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-085490. Derived: 12-month figure less the 9-month figure.Report this figure(31.9)Operating income, Q1 FY2025, three months to 2025-03-31−$31.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure(31.5)Operating income, Q2 FY2025, three months to 2025-06-30−$31.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure(32.9)Operating income, Q3 FY2025, three months to 2025-09-30−$32.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure(36.5)Operating income, Q4 FY2025, three months to 2025-12-31−$36.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-085490. Derived: 12-month figure less the 9-month figure.Report this figure(42.0)Operating income, Q1 FY2026, three months to 2026-03-31−$42.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure(49.0)Operating income, Q2 FY2026, three months to 2026-06-30−$49.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure
Net income$m(21.2)Net income, Q3 FY2023, three months to 2023-09-30−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figure(22.8)Net income, Q4 FY2023, three months to 2023-12-31−$22.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0000950170-25-046124. Derived: 12-month figure less the 9-month figure.Report this figure(18.2)Net income, Q1 FY2024, three months to 2024-03-31−$18.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure(18.7)Net income, Q2 FY2024, three months to 2024-06-30−$18.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure(24.0)Net income, Q3 FY2024, three months to 2024-09-30−$24.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure(25.6)Net income, Q4 FY2024, three months to 2024-12-31−$25.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-085490. Derived: 12-month figure less the 9-month figure.Report this figure(28.1)Net income, Q1 FY2025, three months to 2025-03-31−$28.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure(28.1)Net income, Q2 FY2025, three months to 2025-06-30−$28.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure(29.9)Net income, Q3 FY2025, three months to 2025-09-30−$29.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure(33.8)Net income, Q4 FY2025, three months to 2025-12-31−$33.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-085490. Derived: 12-month figure less the 9-month figure.Report this figure(39.3)Net income, Q1 FY2026, three months to 2026-03-31−$39.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure(45.6)Net income, Q2 FY2026, three months to 2026-06-30−$45.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure
Diluted EPS$ per share(0.49)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figurenot reported(0.35)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure(0.32)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0000950170-25-108899.Report this figure(0.41)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figurenot reported(0.47)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure(0.47)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure(0.50)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figurenot reported(0.64)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure(0.69)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure
Basic EPS$ per share(0.49)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figurenot reported(0.35)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure(0.32)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0000950170-25-108899.Report this figure(0.41)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figurenot reported(0.47)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure(0.47)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure(0.50)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figurenot reported(0.64)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure(0.69)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.69 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure

Balance sheet

Cash and equivalents$73.8m, Q2 FY2026
Shareholders' equity$353.7m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m216Cash and equivalents, Q3 FY2023, at 2023-09-30$215.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figure58.0Cash and equivalents, FY2023, at 2023-12-31$58.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0000950170-25-046124.Report this figure254Cash and equivalents, Q1 FY2024, at 2024-03-31$254.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure99.5Cash and equivalents, Q2 FY2024, at 2024-06-30$99.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0000950170-25-108899.Report this figure104Cash and equivalents, Q3 FY2024, at 2024-09-30$103.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure92.0Cash and equivalents, FY2024, at 2024-12-31$92.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-02, accession 0001193125-26-085490.Report this figure101Cash and equivalents, Q1 FY2025, at 2025-03-31$100.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure98.5Cash and equivalents, Q2 FY2025, at 2025-06-30$98.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure62.0Cash and equivalents, Q3 FY2025, at 2025-09-30$62.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure77.4Cash and equivalents, FY2025, at 2025-12-31$77.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure85.0Cash and equivalents, Q1 FY2026, at 2026-03-31$85.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure73.8Cash and equivalents, Q2 FY2026, at 2026-06-30$73.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure
Current assets$m225Current assets, Q3 FY2023, at 2023-09-30$224.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060276.Report this figure212Current assets, FY2023, at 2023-12-31$211.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046124.Report this figure391Current assets, Q1 FY2024, at 2024-03-31$390.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056971.Report this figure379Current assets, Q2 FY2024, at 2024-06-30$378.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092778.Report this figure366Current assets, Q3 FY2024, at 2024-09-30$365.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figure347Current assets, FY2024, at 2024-12-31$347.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-02, accession 0001193125-26-085490.Report this figure325Current assets, Q1 FY2025, at 2025-03-31$324.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure302Current assets, Q2 FY2025, at 2025-06-30$302.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108899.Report this figure281Current assets, Q3 FY2025, at 2025-09-30$281.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure265Current assets, FY2025, at 2025-12-31$265.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure395Current assets, Q1 FY2026, at 2026-03-31$394.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure367Current assets, Q2 FY2026, at 2026-06-30$367.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure
Total assets$m238Total assets, Q3 FY2023, at 2023-09-30$238.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000950170-23-060276.Report this figure226Total assets, FY2023, at 2023-12-31$225.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0000950170-25-046124.Report this figure405Total assets, Q1 FY2024, at 2024-03-31$404.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0000950170-24-056971.Report this figure392Total assets, Q2 FY2024, at 2024-06-30$392.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0000950170-24-092778.Report this figure381Total assets, Q3 FY2024, at 2024-09-30$380.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figure364Total assets, FY2024, at 2024-12-31$363.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-02, accession 0001193125-26-085490.Report this figure343Total assets, Q1 FY2025, at 2025-03-31$343.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure321Total assets, Q2 FY2025, at 2025-06-30$321.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0000950170-25-108899.Report this figure302Total assets, Q3 FY2025, at 2025-09-30$301.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure283Total assets, FY2025, at 2025-12-31$282.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure412Total assets, Q1 FY2026, at 2026-03-31$412.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure383Total assets, Q2 FY2026, at 2026-06-30$383.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure
Current liabilities$m10.1Current liabilities, Q3 FY2023, at 2023-09-30$10.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060276.Report this figure15.3Current liabilities, FY2023, at 2023-12-31$15.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0000950170-25-046124.Report this figure8.7Current liabilities, Q1 FY2024, at 2024-03-31$8.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0000950170-24-056971.Report this figure10.4Current liabilities, Q2 FY2024, at 2024-06-30$10.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0000950170-24-092778.Report this figure12.4Current liabilities, Q3 FY2024, at 2024-09-30$12.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figure14.6Current liabilities, FY2024, at 2024-12-31$14.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-02, accession 0001193125-26-085490.Report this figure14.2Current liabilities, Q1 FY2025, at 2025-03-31$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure13.8Current liabilities, Q2 FY2025, at 2025-06-30$13.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0000950170-25-108899.Report this figure15.9Current liabilities, Q3 FY2025, at 2025-09-30$15.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure18.1Current liabilities, FY2025, at 2025-12-31$18.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure19.3Current liabilities, Q1 FY2026, at 2026-03-31$19.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure24.6Current liabilities, Q2 FY2026, at 2026-06-30$24.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure
Total liabilities$m16.2Total liabilities, Q3 FY2023, at 2023-09-30$16.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000950170-23-060276.Report this figure21.6Total liabilities, FY2023, at 2023-12-31$21.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0000950170-25-046124.Report this figure14.9Total liabilities, Q1 FY2024, at 2024-03-31$14.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0000950170-24-056971.Report this figure16.4Total liabilities, Q2 FY2024, at 2024-06-30$16.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-07, accession 0000950170-24-092778.Report this figure18.3Total liabilities, Q3 FY2024, at 2024-09-30$18.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figure20.4Total liabilities, FY2024, at 2024-12-31$20.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-02, accession 0001193125-26-085490.Report this figure19.9Total liabilities, Q1 FY2025, at 2025-03-31$19.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure19.4Total liabilities, Q2 FY2025, at 2025-06-30$19.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0000950170-25-108899.Report this figure21.3Total liabilities, Q3 FY2025, at 2025-09-30$21.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure23.4Total liabilities, FY2025, at 2025-12-31$23.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure24.5Total liabilities, Q1 FY2026, at 2026-03-31$24.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure29.7Total liabilities, Q2 FY2026, at 2026-06-30$29.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure
Shareholders' equity$m222Shareholders' equity, Q3 FY2023, at 2023-09-30$222.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figure204Shareholders' equity, FY2023, at 2023-12-31$204.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-02, accession 0001193125-26-085490.Report this figure390Shareholders' equity, Q1 FY2024, at 2024-03-31$389.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure376Shareholders' equity, Q2 FY2024, at 2024-06-30$376.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure362Shareholders' equity, Q3 FY2024, at 2024-09-30$362.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure343Shareholders' equity, FY2024, at 2024-12-31$343.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure324Shareholders' equity, Q1 FY2025, at 2025-03-31$323.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure302Shareholders' equity, Q2 FY2025, at 2025-06-30$302.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure281Shareholders' equity, Q3 FY2025, at 2025-09-30$280.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure259Shareholders' equity, FY2025, at 2025-12-31$259.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure388Shareholders' equity, Q1 FY2026, at 2026-03-31$387.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure354Shareholders' equity, Q2 FY2026, at 2026-06-30$353.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure

Cash flow

Operating cash flow−$31.1m, Q2 FY2026
Capital expenditure$66.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(17.1)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$17.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0000950170-24-123346. Derived: 9-month figure less the 6-month figure.Report this figure(13.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$13.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0000950170-25-046124. Derived: 12-month figure less the 9-month figure.Report this figure(22.0)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$22.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure(10.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0000950170-25-108899. Derived: 6-month figure less the 3-month figure.Report this figure(17.9)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$17.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266967. Derived: 9-month figure less the 6-month figure.Report this figure(19.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$19.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001193125-26-085490. Derived: 12-month figure less the 9-month figure.Report this figure(25.5)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$25.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure(23.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$23.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-332995. Derived: 6-month figure less the 3-month figure.Report this figure(22.4)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$22.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266967. Derived: 9-month figure less the 6-month figure.Report this figure(23.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$23.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001193125-26-085490. Derived: 12-month figure less the 9-month figure.Report this figure(32.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$32.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure(31.1)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$31.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-332995. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.1Capital expenditure, Q3 FY2023, three months to 2023-09-30$83.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0000950170-24-123346. Derived: 9-month figure less the 6-month figure.Report this figure0.6Capital expenditure, Q4 FY2023, three months to 2023-12-31$603.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0000950170-25-046124. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$136.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure0.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$470.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-14, accession 0000950170-25-108899. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q3 FY2024, three months to 2024-09-30$52.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266967. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001193125-26-085490. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$31.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-332995. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$39.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266967. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2025, three months to 2025-12-31$57.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001193125-26-085490. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$88.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$66.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-332995. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)65.99m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares42.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3041,997,195 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000950170-23-060276.Report this figure42.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3142,394,623 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0000950170-24-056971.Report this figure42.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3042,589,213 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-07, accession 0000950170-24-092778.Report this figure42.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3042,868,340 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0000950170-24-123346.Report this figure52.2Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3152,228,934 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-08, accession 0000950170-25-066942.Report this figure58.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3058,668,712 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0000950170-25-108899.Report this figure58.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3058,874,497 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure59.3Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3159,336,550 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure59.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3059,550,771 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure59.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3059,670,757 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0001193125-25-266967.Report this figure61.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3161,746,050 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001193125-26-220645.Report this figure66.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3065,991,171 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure

Shares outstanding: 59.68mShares outstanding, period not labelled, at 2026-07-3159,676,939 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332995.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.